Title:
METHOD PERFORMED BY ACCESS NETWORK NODE, METHOD PERFORMED BY USER EQUIPMENT (UE), ACCESS NETWORK NODE, UE
Document Type and Number:
WIPO Patent Application WO/2024/075752
Kind Code:
A1
Abstract:
An access network node is disclosed that transmits first information for configuring time domain resources with a downlink (DL) frequency region and an uplink (UL) frequency region. The access network node communicates with a UE in the time domain resources in a manner that avoids overlap between a UL frequency region and resources for DL communication or a DL frequency region and resources for UL communication.
Inventors:
IJAZ AYESHA (JP)
DEOGUN PRAVJYOT (JP)
DEOGUN PRAVJYOT (JP)
Application Number:
PCT/JP2023/036122
Publication Date:
April 11, 2024
Filing Date:
October 03, 2023
Export Citation:
Assignee:
NEC CORP (JP)
International Classes:
H04L5/00
Foreign References:
US20210400654A1 | 2021-12-23 | |||
GB202214820A | 2022-10-07 |
Other References:
MEDIATEK INC: "Discussion on subband non-overlapping full duplex for NR", vol. RAN WG1, no. Toulouse, France; 20220822 - 20220826, 12 August 2022 (2022-08-12), XP052274921, Retrieved from the Internet [retrieved on 20220812]
SAMSUNG: "SBFD feasibility and design considerations for NR duplex evolution", vol. RAN WG1, no. Toulouse, France; 20220822 - 20220826, 12 August 2022 (2022-08-12), XP052274353, Retrieved from the Internet [retrieved on 20220812]
NEXT GENERATION MOBILE NETWORKS (NGMN) ALLIANCE, NGMN 5G WHITE PAPER, Retrieved from the Internet
SAMSUNG: "SBFD feasibility and design considerations for NR duplex evolution", vol. RAN WG1, no. Toulouse, France; 20220822 - 20220826, 12 August 2022 (2022-08-12), XP052274353, Retrieved from the Internet
NEXT GENERATION MOBILE NETWORKS (NGMN) ALLIANCE, NGMN 5G WHITE PAPER, Retrieved from the Internet
Attorney, Agent or Firm:
IEIRI Takeshi (JP)
Download PDF:
Previous Patent: HUMAN BODY MEASUREMENT DEVICE AND MEASUREMENT METHOD
Next Patent: SYNTHETIC FIBER TREATMENT AGENT AND SYNTHETIC FIBER
Next Patent: SYNTHETIC FIBER TREATMENT AGENT AND SYNTHETIC FIBER